培哚普利

péi duǒ pǔ lì
  • Perindopril
培哚普利培哚普利
  1. 血钾在卡托普利组和培哚普利组均有上升(P<0.005和P<0.05),血钠水平3组间均无变化。

    Plasma K + increased in the groups of captopril ( p < 0.005 ) and perindopril ( p < 0.05 ) but not in the nifedipine group .

  2. 结论:培哚普利对DN肾功能的保护作用和其改善内皮细胞功能密切相关。

    Conclusion : Perindopril might protect renal function through improving endothelia function during diabetic nephropathy .

  3. B组为治疗组28例,在控制血糖基础上加用培哚普利4mg/d和羟苯磺酸钙3000mg/d(分3次口服)。

    Group B of 28 cases as therapy group was treated 3 000 mg / d ( t.i.d. )

  4. 慢性低O2高CO2性肺动脉高压大鼠脑超微结构改变与MDA、SOD变化及培哚普利的治疗作用

    Changes of the brain ultrastructure and MDA and SOD and effects of perindopril in pulmonary hypertension rats induced by chronic hypoxia-hypercapnia

  5. 结论培哚普利可降低EH患者血浆ET、ANP水平,从而有助于降低血压。

    Conclusion The influence of perindopril on ET and ANP is correlated to its hypotensive effects in EH patients .

  6. 用QRS积分方法评价培哚普利对急性前壁心肌梗死的影响

    The Evaluation of Perindopril in the Treatment of Acute Anterior Myocardial Infarction by QRS Scoring System

  7. 培哚普利对正常和DM大鼠肢体缺血性血管再生均具有促进作用,这种影响在DM组的表现更为显著。

    Treatment of perindopril improved angiogenesis in normal and diabetic ischemic leg . And this effect is more obvious in diabetic rats .

  8. 培哚普利可通过降低TGF-β1和MMP-2的表达进而抑制肾性高血压大鼠心肌纤维化的进展。

    Perindopril can inhibit progress of RH rat myocardial fibrosis by inhibiting the expression of MMP-2 and TGF - β 1 .

  9. 培哚普利对大鼠心肌梗死边缘区Cx43及MMP-7表达的影响

    Effect of Perindopril on the Expression of Cx43 and MMP-7 in Infarct Border Zone

  10. 培哚普利对心肌梗死大鼠左室重构和心肌组织osteopontin蛋白表达的影响

    Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction

  11. 观察了培哚普利(Per)对心肌梗塞(MI)后心力衰竭(HF)大鼠左室舒张功能的影响。

    WC observed the effect of Perindopril ( Per ) on left ventricular diastolic function in rat hearts with cardiac failure induced by myocardial infarction ( MI ) .

  12. 在观察期间高血压患者给予培哚普利片4mg,qd。

    During observation , hypertensive patients are given to perindopril ( 4mg / day ) .

  13. 培哚普利对Duchenne肌营养不良患者左心室功能不全发生、发展的影响

    Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy

  14. 目的:探索培哚普利对原发性高血压(EH)合并外周动脉病变(PAD)的影响。

    AIM : To study the effect of perindopril in treating essential hypertensive ( EH ) class II accompanied with peripheral arterial disease ( PAD ) .

  15. BNP与急性心肌梗死后左室重构的相关性及培哚普利的影响

    The correlation between brain natriuretic peptide and left ventricular remodeling in patients after acute myocardial infarction and the influence of perindopril to BNP

  16. 目的观察肾素血管紧张素系统(RAS)对大鼠心肌缺血和缺血再灌注后左心室功能的影响,以及给予氯沙坦和培哚普利干预的结果。

    Objective To investigate the effect of RAS on left ventricular function after myocardial ischemia and reperfusion in rats , and the effects of losartan and perindopril .

  17. 目的观察培哚普利与氯沙坦联合治疗老年性慢性心力衰竭(CHF)对心室重构与血脑利钠肽(BNP)水平的影响。

    Objective To observe the effect of perindopril and losartan on ventricular remodeling and the level of brain natriuretic peptide ( BNP ) in the senile CHF treatment .

  18. 氯沙坦及培哚普利对高糖诱导NRK-52E细胞转分化作用研究

    Effect of losartan and perindopril on hyperglycemia inducing transdifferentiation in NRK-52E

  19. 目的观察培哚普利对老年慢性心力衰竭(CHF)患者循环血中可溶性细胞间黏附分子1(sICAM1)和细胞凋亡抑制因子(FasApo1)水平的影响。

    Objective To explore the effects of perindopril on circulating levels of soluble intercellular adhesion molecule-1 ( sICAM-1 ) and Fas / Apo-1 in elderly patients with congestive heart failure ( CHF ) .

  20. 本课题的目的在于探讨DM大鼠肢体缺血性血管再生受损的原因以及ACEI-培哚普利在缺血后血管再生中的作用及相关分子通路。

    The aim of our study is to investigate the reasons of the impaired angiogenesis in diabetic ischemic hind limbs of rats 、 the role and related molecular mechanisms of ACEI in limbs ' postischemic revascularization .

  21. 培哚普利对24h动态血压趋于正常者治疗后降压疗效不明显(P>0.05),而对符合动态EH诊断标准者,降压疗效显著(P<0.05或0.01);

    The antihypertensive efficacy was significant in patients with ambulatory EH ( P0 . 05 or 0 . 01 ), while the reduction of blood pressure was less outstanding in patients tending to normal 24 h blood pressure ( P0.05 ) .

  22. 【目的】观察培哚普利联合厄贝沙坦对扩张型心肌病(DCM)大鼠的心功能及心肌核因子-κB(NF-κB)活性的影响。

    【 Objective 】 To evaluate the effects of combination therapy with perindopril and irbesartan on cardiac function and the activity of NF-kappa B ( NF - κ B ) in the myocardium of rat model of dilated cardiomyopathy ( DCM ) .

  23. 两者降低的谷/峰比满意,氯沙坦降压的SBP和DBPT/P比分别为683%和797%,培哚普利分别为684%和798%;

    T / P ratio of losartan was 68 3 % for SBP and 79 7 % for DBP , perindopril was 68 4 % and 79 8 % .

  24. 在CHF患者中采用小剂量逐渐递增剂量的方式给予培哚普利可明显降低BNP、NE,患者耐受性良好。

    Giving perindopril to patients in the heart failure at low dosage initially and gradually increasing to the high dosage could decrease the plasma BNP and NE levels . Patients tolerated it well .

  25. 目的了解高血压病(EH)患者血浆可溶性细胞间粘附分子1(sICAM1)和内皮素(ET)浓度的相关性及培哚普利对其的影响。

    Objective To measure the relationship between plasma soluble intercellular adhesion molecule 1 ( sICAM 1 ) and endothelin ( ET ) in the patients with essential hypertension ( EH ) and its changes after perindopril treatment .

  26. 目的:评价培哚普利对房间隔缺损(ASD)封堵术后右心大小、功能以及抗心律失常的作用。

    AIM : To evaluate the effects of perindopril on right cardiac size , its function and antiarrhythmias after transcatheter closure of adult secundum atrial septal defect ( ASD ) .

  27. 目的观察培哚普利急性心肌梗死患者(AMI)循环血可溶性细胞黏附分子-1(sICAM-1)和细胞凋亡因子(Fas/Apo-1)水平的影响。

    [ Objective ] To explore the effectors of perindopril on circulating levels of soluble intercellular adhesions molecule-1 ( sICAM-1 ) and Fas / Apo-1 in patients with acute myocardial infarction .

  28. 培哚普利联合厄贝沙坦调节扩张型心肌病大鼠AT1受体和LaminA表达

    Combination Therapy with Perindopril and Irbesartan Regulates the Expression of AT_1 Receptor and Lamin A in a Rat Model of Dilated Cardiomyopathy

  29. 结论应用血管紧张素转换酶抑制剂(ACEI)治疗原发性高血压时,宜首选培哚普利。

    Conclusion It is suggested that perindopril should be the first choice when angiotensin converting enzyme inhibitor ( ACEI ) is taken into account for the therapy of primary hypertension .

  30. 给予EH患者培哚普利片4mg,qd,口服2周后,若收缩压(SBP)>140mmHg或舒张压(DBP)>90mmHg,则增加剂量至4mg,bid。

    The EH patients are given perindopril ( 4mg / d ) . After two weeks treatment , if SBP > 140 mmHg or DBP > 90 mmHg , the dosage are increased .